| Dr Dana Sainsbury Smith, MD | |
|
9900 Se Sunnyside Rd, Clackamas, OR 97015-9777 | |
| (503) 571-3995 | |
| Not Available |
| Full Name | Dr Dana Sainsbury Smith |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 9900 Se Sunnyside Rd, Clackamas, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699855437 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Acorda Therapeutics, Inc, today announced that data from preclinical studies show that Glial Growth Factor 2 (GGF2) promoted functional recovery following a permanent focal ischemic stroke.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
ZirMed®, a leading national revenue cycle management software and solutions provider to the healthcare industry, today announced the immediate availability of its new Denial Management and Decision Support (DMDS) solution, part of ZirMed's Analytics services.
› Verified 6 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Acorda Therapeutics, Inc, today announced that data from preclinical studies show that Glial Growth Factor 2 (GGF2) promoted functional recovery following a permanent focal ischemic stroke.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
ZirMed®, a leading national revenue cycle management software and solutions provider to the healthcare industry, today announced the immediate availability of its new Denial Management and Decision Support (DMDS) solution, part of ZirMed's Analytics services.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana Sainsbury Smith, MD 9900 Se Sunnyside Rd, Clackamas, OR 97015-9777 Ph: (503) 571-3995 | Dr Dana Sainsbury Smith, MD 9900 Se Sunnyside Rd, Clackamas, OR 97015-9777 Ph: (503) 571-3995 |
News Archive
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Acorda Therapeutics, Inc, today announced that data from preclinical studies show that Glial Growth Factor 2 (GGF2) promoted functional recovery following a permanent focal ischemic stroke.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
ZirMed®, a leading national revenue cycle management software and solutions provider to the healthcare industry, today announced the immediate availability of its new Denial Management and Decision Support (DMDS) solution, part of ZirMed's Analytics services.
› Verified 6 days ago
Anna Helen Grosz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-3995 | |
Caroline Yi Yang, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9800 Se Sunnyside Rd., Clackamas, OR 97015 Phone: 503-653-6440 | |
Haena Kim, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 9280 Se Sunnybrook Blvd Ste 300, Clackamas, OR 97015 Phone: 503-233-5548 Fax: 503-230-1009 | |
Mitch Edmond Brock, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-653-6440 | |
Geoffrey Lawrence, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-653-6440 | |
Dr. Sharon Marie Higgins, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-3865 | |
Dr. Clee E Lloyd, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-3199 Fax: 503-571-9004 |